TFFP - TFF Pharmaceuticals, Inc.

0.073
-2.267   -3,105.479%

Share volume: 0
Last Updated: 12-12-2024

PREVIOUS CLOSE
CHG
CHG%
$2.34
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-76.88%
3 Months
-96.45%
6 Months
-96.68%
1 Year
-98.91%
2 Year
-99.76%
Key data
Stock price
$0.07
P/E Ratio 
0.00
DAY RANGE
$0.08 - $2.34
EPS 
$0.00
52 WEEK RANGE
$0.09 - $11.00
52 WEEK CHANGE
-$98.78
MARKET CAP 
6.967 M
YIELD 
N/A
SHARES OUTSTANDING 
3.466 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
$4,778,492
Company detail
CEO: Glenn R. Mattes
Region: US
Website: tffpharma.com
Employees: 0
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was incorporated in 2018 and is based in Austin, Texas.

Recent news